HEADER TRANSFERASE/TRANSFERASE INHIBITOR 20-FEB-21 7LTZ TITLE BRUTON'S TYROSINE KINASE IN COMPLEX WITH COMPOUND 51 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ISOFORM BTK-C OF TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN, RESIDUES 427-693; COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 6 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS TRANSFERASE, TRANSFERASE INHIBITOR, KINASE, KINASE INHIBITOR, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.M.METRICK,D.J.MARCOTTE REVDAT 3 18-OCT-23 7LTZ 1 REMARK REVDAT 2 09-FEB-22 7LTZ 1 JRNL REVDAT 1 12-JAN-22 7LTZ 0 JRNL AUTH B.T.HOPKINS,E.BAME,B.BAJRAMI,C.BLACK,T.BOHNERT,C.BOISELLE, JRNL AUTH 2 D.BURDETTE,J.C.BURNS,L.DELVA,D.DONALDSON,R.GRATER,C.GU, JRNL AUTH 3 M.HOEMBERGER,J.JOHNSON,S.KAPADNIS,K.KING,M.LULLA,B.MA, JRNL AUTH 4 I.MARX,T.MAGEE,R.MEISSNER,C.M.METRICK,M.MINGUENEAU, JRNL AUTH 5 P.MURUGAN,K.L.OTIPOBY,E.POLACK,U.PORECI,R.PRINCE,A.M.ROACH, JRNL AUTH 6 C.ROWBOTTOM,J.C.SANTORO,P.SCHROEDER,H.TANG,E.TIEN,F.ZHANG, JRNL AUTH 7 J.LYSSIKATOS JRNL TITL DISCOVERY AND PRECLINICAL CHARACTERIZATION OF BIIB091, A JRNL TITL 2 REVERSIBLE, SELECTIVE BTK INHIBITOR FOR THE TREATMENT OF JRNL TITL 3 MULTIPLE SCLEROSIS. JRNL REF J.MED.CHEM. V. 65 1206 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 34734694 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00926 REMARK 2 REMARK 2 RESOLUTION. 1.53 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19_4080 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.53 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.47 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 44175 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 2184 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.4700 - 3.8500 0.98 2808 158 0.1508 0.1498 REMARK 3 2 3.8500 - 3.0600 1.00 2775 128 0.1646 0.2410 REMARK 3 3 3.0600 - 2.6700 0.99 2681 159 0.1892 0.2354 REMARK 3 4 2.6700 - 2.4300 0.99 2662 126 0.1847 0.2165 REMARK 3 5 2.4300 - 2.2500 0.98 2615 151 0.1711 0.1704 REMARK 3 6 2.2500 - 2.1200 0.98 2626 122 0.1609 0.2307 REMARK 3 7 2.1200 - 2.0100 0.98 2616 128 0.1685 0.1891 REMARK 3 8 2.0100 - 1.9300 0.98 2602 122 0.1730 0.2047 REMARK 3 9 1.9300 - 1.8500 0.97 2598 146 0.1847 0.2206 REMARK 3 10 1.8500 - 1.7900 0.97 2570 131 0.1874 0.2498 REMARK 3 11 1.7900 - 1.7300 0.97 2592 130 0.1965 0.2355 REMARK 3 12 1.7300 - 1.6800 0.97 2562 123 0.2076 0.2332 REMARK 3 13 1.6800 - 1.6400 0.98 2606 136 0.2242 0.2410 REMARK 3 14 1.6400 - 1.6000 0.98 2549 146 0.2349 0.2985 REMARK 3 15 1.6000 - 1.5600 0.98 2606 128 0.2640 0.3029 REMARK 3 16 1.5600 - 1.5300 0.98 2571 150 0.2809 0.3225 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.647 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.53 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.013 2295 REMARK 3 ANGLE : 1.302 3109 REMARK 3 CHIRALITY : 0.079 329 REMARK 3 PLANARITY : 0.013 393 REMARK 3 DIHEDRAL : 15.467 878 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7LTZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1000255008. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44179 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.530 REMARK 200 RESOLUTION RANGE LOW (A) : 28.470 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.53 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.43710 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 3GEN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BISTRIS PH 6.5, 0.2M AMMONIUM REMARK 280 ACETATE, 0.1M GUANIDINE HCL, 20% PEG2200 MME, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 36.53400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.00300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.53400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.00300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 393 REMARK 465 SER A 659 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 434 CD OE1 OE2 REMARK 470 GLU A 455 CG CD OE1 OE2 REMARK 470 GLN A 467 CG CD OE1 NE2 REMARK 470 GLN A 496 CG CD OE1 NE2 REMARK 470 LYS A 595 CD CE NZ REMARK 470 ARG A 600 CD NE CZ NH1 NH2 REMARK 470 GLN A 612 CG CD OE1 NE2 REMARK 470 LYS A 637 CG CD CE NZ REMARK 470 GLU A 658 C O CB CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 424 -43.31 -140.34 REMARK 500 ARG A 520 -9.58 82.26 REMARK 500 ASP A 521 53.24 -149.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1063 DISTANCE = 7.08 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6W07 RELATED DB: PDB REMARK 900 6W07 CONTAINS THE SAME PROTEIN AND A PRECURSOR COMPOUND REMARK 900 RELATED ID: 7LTY RELATED DB: PDB REMARK 900 7LTY CONTAINS THE SAME PROTEIN AND A PRECURSOR COMPOUND DBREF 7LTZ A 393 659 UNP Q06187 BTK_HUMAN 427 693 SEQRES 1 A 267 GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR PHE LEU SEQRES 2 A 267 LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR SEQRES 3 A 267 GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET SEQRES 4 A 267 ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU SEQRES 5 A 267 GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU SEQRES 6 A 267 VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE SEQRES 7 A 267 PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU LEU SEQRES 8 A 267 ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN SEQRES 9 A 267 GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET SEQRES 10 A 267 GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU SEQRES 11 A 267 ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL SEQRES 12 A 267 LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP SEQRES 13 A 267 ASP GLU TYR THR SER SER VAL GLY SER LYS PHE PRO VAL SEQRES 14 A 267 ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE SEQRES 15 A 267 SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET SEQRES 16 A 267 TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG SEQRES 17 A 267 PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY SEQRES 18 A 267 LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL SEQRES 19 A 267 TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP SEQRES 20 A 267 GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU SEQRES 21 A 267 ASP VAL MET ASP GLU GLU SER HET YDA A 701 40 HET DTT A 702 8 HET ACT A 703 4 HET ACT A 704 4 HETNAM YDA 1-~{TERT}-BUTYL-~{N}-[(5~{R})-8-[2-[(1-METHYLPYRAZOL-4- HETNAM 2 YDA YL)AMINO]PYRIMIDIN-4-YL]-2-(OXETAN-3-YL)-1,3,4,5- HETNAM 3 YDA TETRAHYDRO-2-BENZAZEPIN-5-YL]-1,2,3-TRIAZOLE-4- HETNAM 4 YDA CARBOXAMIDE HETNAM DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE HETNAM ACT ACETATE ION HETSYN DTT 1,4-DITHIOTHREITOL FORMUL 2 YDA C28 H34 N10 O2 FORMUL 3 DTT C4 H10 O2 S2 FORMUL 4 ACT 2(C2 H3 O2 1-) FORMUL 6 HOH *263(H2 O) HELIX 1 AA1 ASP A 398 LYS A 400 5 3 HELIX 2 AA2 SER A 438 MET A 450 1 13 HELIX 3 AA3 CYS A 481 GLU A 488 1 8 HELIX 4 AA4 MET A 489 ARG A 492 5 4 HELIX 5 AA5 GLN A 494 LYS A 515 1 22 HELIX 6 AA6 ALA A 523 ARG A 525 5 3 HELIX 7 AA7 GLY A 541 VAL A 546 5 6 HELIX 8 AA8 ASP A 548 SER A 553 1 6 HELIX 9 AA9 PRO A 560 SER A 564 5 5 HELIX 10 AB1 PRO A 565 SER A 572 1 8 HELIX 11 AB2 SER A 575 SER A 592 1 18 HELIX 12 AB3 THR A 602 GLN A 612 1 11 HELIX 13 AB4 SER A 623 CYS A 633 1 11 HELIX 14 AB5 LYS A 637 ARG A 641 5 5 HELIX 15 AB6 THR A 643 GLU A 658 1 16 SHEET 1 AA1 5 LEU A 402 GLY A 411 0 SHEET 2 AA1 5 GLY A 414 TRP A 421 -1 O TYR A 418 N LYS A 406 SHEET 3 AA1 5 TYR A 425 MET A 431 -1 O ILE A 429 N LYS A 417 SHEET 4 AA1 5 PHE A 471 THR A 474 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N TYR A 461 O ILE A 473 SHEET 1 AA2 2 CYS A 527 VAL A 529 0 SHEET 2 AA2 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 LINK SG CYS A 481 S1 DTT A 702 1555 1555 2.02 CISPEP 1 ARG A 468 PRO A 469 0 5.51 CRYST1 73.068 104.006 38.446 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013686 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009615 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026011 0.00000